- pause slideshow
All preregistration pharmacists on the provisional register must be risk-assessed by their employer before they can start work, the General Pharmaceutical Council has said.
A Public Health England-approved COVID-19 antibody test that was being sold for use at home with a finger-prick blood test is not intended to be used in this way, the manufacturer has said.
Community pharmacists in Scotland have begun trialling the ‘NHS Near Me’ video consultation service, and talks have taken place with the Scottish government on how the system could be deployed across community pharmacy.
Pharmacies have been listed as a “target setting” for COVID-19 antibody tests under specifications published by the Medicines and Healthcare products Regulatory Agency.
The investigational antiviral medicine, remdesivir, may be granted a conditional marketing authorisation as a treatment for COVID-19 “in the coming days”, the head of the European Medicines Agency has said.
The use of corticosteroids in coronavirus infections is associated with increased risk of death and side effects, such as bacterial infections and hypokalaemia, researchers have said.
Among people with hypertension, the severity of COVID-19 is not associated with the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, data from Wuhan, China, suggest.
Daily multidisciplinary team (MDT) meetings significantly reduced the length of hospital stay for patients with COPD, a study published in the Journal of the American Osteopathic Association has found.
Adults with non-valvular atrial fibrillation prescribed apixaban have a lower rate of ischaemic stroke and systemic blood clots compared with those prescribed rivaroxaban, according to a retrospective cohort study in Annals of Internal Medicine.
Neurological symptoms are common in patients with COVID-19, particularly if they have a severe infection, research published in JAMA Neurology suggests.
The latest information about the novel coronavirus identified in Wuhan, China, and advice on how pharmacists can help concerned patients and the public.
Community pharmacy is providing a vital connection to support older and clinically vulnerable patients during lockdown in the UK.
Members of the Royal Pharmaceutical Society from around the world explain how their practice has changed in the face of COVID-19.
The temporary field hospitals set up across the UK to help the NHS cope during the COVID-19 pandemic have given hospital pharmacists a unique opportunity for valuable learning and teamwork.
The NHS is rapidly enrolling patients into studies as part of a focused international effort to find medicines that will interfere with viral replication or help modulate the immune system response.